Published in Physiol Res on January 01, 2003
Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol (2009) 1.36
The mechanosensory role of primary cilia in vascular hypertension. Int J Vasc Med (2011) 0.89
Pkd2 mesenteric vessels exhibit a primary defect in endothelium-dependent vasodilatation restored by rosiglitazone. Am J Physiol Heart Circ Physiol (2012) 0.82
Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective. Int J Nephrol Urol (2010) 0.82
The importance of total kidney volume in evaluating progression of polycystic kidney disease. Nat Rev Nephrol (2016) 0.78
Distinctive expression patterns of hypoxia-inducible factor-1α and endothelial nitric oxide synthase following hypergravity exposure. Oncotarget (2016) 0.78
Heterotrimeric G protein signaling in polycystic kidney disease. Physiol Genomics (2016) 0.75
Endothelin 1 gene is not a major modifier of chronic kidney disease advancement among the autosomal dominant polycystic kidney disease patients. J Nephropharmacol (2015) 0.75
Pseudotypes of vesicular stomatitis virus with the coat of murine leukaemia and of avian myeloblastosis viruses. J Gen Virol (1972) 2.82
Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics (1996) 2.34
A novel quasi-viral agent, MaTu, is a two-component system. Virology (1992) 2.22
[Ferritin, oxidative stress and coronary atherosclerosis]. Vnitr Lek (2004) 2.08
The pseudotypic paradox. J Gen Virol (1982) 1.83
Human cell surface proteins selectively assembled into vesicular stomatitis virus virions. Virology (1983) 1.74
Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol (1994) 1.69
VSV pseudotype particles with the coat of avian myeloblastosis virus. Nat New Biol (1972) 1.49
[Clinical spectrum of the antiphospholipid syndrome]. Cas Lek Cesk (1997) 1.39
Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res (2002) 1.31
Phenotypic mixing of vesicular stomatitis virus with fowl plague virus. Acta Virol (1972) 1.30
Viral pseudotypes and phenotypic mixing. Arch Virol (1976) 1.26
Pseudotypes of vesicular stomatitis virus with envelope antigens provided by murine mammary tumor virus. Virology (1977) 1.21
Ethanol and oxidative stress. Alcohol Clin Exp Res (2001) 1.07
Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study. Scand J Rheumatol (2013) 1.05
Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors. J Hum Hypertens (2002) 1.05
Complementation and phenotypic stabilization of vesicular stomatitis virus temperature-sensitive and thermolabile mutants by avian myeloblastosis virus. Intervirology (1974) 1.04
Primary Sjögren's syndrome in children and adolescents: proposal for diagnostic criteria. Clin Exp Rheumatol (1999) 1.00
Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients. Blood Purif (1998) 0.92
Assembly of xenotropic murine leukaemia virus-related antigens from the surface of mouse L cells by vesicular stomatitis virus. Acta Virol (1983) 0.92
Trace elements in end-stage renal disease. 2. Clinical implication of trace elements. Blood Purif (1999) 0.92
Acute renal failure due to bilateral renal artery thrombosis associated with primary antiphospholipid syndrome. Nephrol Dial Transplant (1998) 0.92
Exposure to silica and risk of ANCA-associated vasculitis. Am J Ind Med (2006) 0.92
Culture methods of glomerular podocytes. Kidney Blood Press Res (2007) 0.91
[Diabetes, dyslipidaemia and kidney diseases]. Vnitr Lek (2008) 0.91
Antibodies against oxidized LDL--theory and clinical use. Physiol Res (2001) 0.90
Deoxyspergualin in relapsing and refractory Wegener's granulomatosis. Ann Rheum Dis (2008) 0.90
The effect of quinolinate on rat brain lipid peroxidation is dependent on iron. Neurochem Int (1997) 0.90
Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease? Kidney Blood Press Res (2009) 0.89
Y-chromosome transfer induces changes in blood pressure and blood lipids in SHR. Hypertension (2001) 0.89
Antioxidant enzymes and lipid peroxidation in patients with multiple myeloma. Neoplasma (1996) 0.89
Mechanisms of chronic heart failure development in end-stage renal disease patients on chronic hemodialysis. Physiol Res (2008) 0.88
Comparison of different immunoassays for CA 19-9. Clin Chem Lab Med (2001) 0.88
Cytokine profile in autosomal dominant polycystic kidney disease. Biochem Mol Biol Int (1997) 0.88
Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes (2012) 0.88
Impact of risk factors on prevalence of anal HPV infection in women with simultaneous cervical lesion. Neoplasma (2015) 0.87
Soluble TNF and IL-2 receptors in patients with breast cancer. Med Sci Monit (2001) 0.87
Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study. Lupus (2010) 0.86
[Urinary tract infection in patients with diabetes mellitus]. Vnitr Lek (2006) 0.86
Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities. Kidney Blood Press Res (2004) 0.86
Influence of plasma exchange on serum levels of cytokines and adhesion molecules in ANCA-positive renal vasculitis. Blood Purif (1998) 0.85
[The production and properties of human immunoglobulin G-anti-D (Halle)]. Dtsch Gesundheitsw (1970) 0.85
Levels of circulating biomarkers at rest and after exercise in coronary artery disease patients. Physiol Res (2009) 0.85
Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus. Neoplasma (2011) 0.84
Oxidative stress and inflammation in pregnancy. Scand J Clin Lab Invest (2006) 0.84
Clinical features and natural history of IgA nephropathy. Ann Med Interne (Paris) (1999) 0.84
Immunohistochemistry and serum values of S-100B, glial fibrillary acidic protein, and hyperphosphorylated neurofilaments in brain injuries. Soud Lek (2012) 0.84
Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease. Kidney Blood Press Res (2006) 0.84
Carbonyl and oxidative stress in patients with breast cancer--is there a relation to the stage of the disease? Neoplasma (2007) 0.84
Transjugular renal biopsy. Our experience with 67 cases. Kidney Blood Press Res (2001) 0.84
Chromium levels in patients with internal diseases. Biochem Mol Biol Int (1998) 0.83
Lipid peroxidation and superoxide dismutase activity in umbilical and maternal blood. Biochem Mol Biol Int (1995) 0.83
Incomplete distal renal tubular acidosis coinherited with a mutation in the band 3 (AE1) gene. Nephrol Dial Transplant (1997) 0.83
Association analysis of Arg16Gly polymorphism of the beta2-adrenergic receptor gene in offspring from hypertensive and normotensive families. Blood Press (2002) 0.83
ICRF-187 (dexrazoxan) protects from adriamycin-induced nephrotic syndrome in rats. Nephrol Dial Transplant (1998) 0.83
A novel method for the estimation of podocyte injury: podocalyxin-positive elements in urine. Folia Biol (Praha) (2008) 0.83
Decreased levels of advanced glycation end-products in patients with Gilbert syndrome. Cell Mol Biol (Noisy-le-grand) (2005) 0.83
Renal AA amyloidosis: survey of epidemiologic and laboratory data from one nephrology centre. Int Urol Nephrol (2009) 0.82
Paraoxonase-1 (PON1) status in pancreatic cancer: relation to clinical parameters. Folia Biol (Praha) (2012) 0.82
Influence of the alpha-adducin and ACE gene polymorphism on the progression of autosomal-dominant polycystic kidney disease. Kidney Blood Press Res (2003) 0.82
Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patients. Nephrol Dial Transplant (2003) 0.82
Pseudotype particles of vesicular stomatitis virus with surface antigens of bovine leukaemia virus--VSV (BLV) -- as a sensitive probe for detecting antibodies in the sera of spontaneously infected cattle. Acta Virol (1978) 0.82
Genetic basis of nephrotic syndrome--review. Prague Med Rep (2006) 0.81
TRPC6 gene variants in Czech adult patients with focal segmental glomerulosclerosis and minimal change disease. Folia Biol (Praha) (2012) 0.81
Event-related potentials in evaluation of metabolic encephalopathies. Schweiz Arch Neurol Psychiatr (1993) 0.80
DNA analysis of renal electrolyte transporter genes among patients suffering from Bartter and Gitelman syndromes: summary of mutation screening. Folia Biol (Praha) (2011) 0.80
Further characterization of proteins assembled by vesicular stomatitis virus from human tumor cells. Virology (1984) 0.80
Miotic action of tramadol is determined by CYP2D6 genotype. Physiol Res (2006) 0.80
[Lipid peroxidation and activity of antioxidative enzymes in patients with multiple myeloma]. Cas Lek Cesk (1996) 0.80
Inflammatory cytokine profile in autosomal dominant polycystic kidney disease. Contrib Nephrol (1997) 0.80
VSV pseudotype produced in cell line derived from human mammary carcinoma. Nat New Biol (1972) 0.80
[Hypertension in patients with polycystic kidney disease - incidence, pathogenesis, prognosis, therapy]. Vnitr Lek (2013) 0.80
Association of the -344T/C aldosterone synthase gene variant with essential hypertension. Physiol Res (2008) 0.80
Pregnancy-associated plasma protein-A in patients with cerebrovascular diseases--a pilot study. Prague Med Rep (2006) 0.80
Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats. Physiol Res (2004) 0.80
Metabolic, humoral and haemodynamic characteristics of normotensive offspring from hypertensive families. J Hum Hypertens (1996) 0.80
Impact of antihypertensive therapy on the skeleton: effects of enalapril and AT1 receptor antagonist losartan in female rats. Physiol Res (2001) 0.80
Effect of acute hyperglycaemia on selected plasma and urinary cytokine antagonists in Type 1 diabetes mellitus. Diabetologia (2003) 0.80
Genetic variation screening of TNNT2 gene in a cohort of patients with hypertrophic and dilated cardiomyopathy. Physiol Res (2012) 0.80
Recent insights into the pathogenesis of nephrotic syndrome. Minerva Med (2013) 0.79
Preeclampsia, dilated cardiomyopathy and renal failure as the first manifestation of systemic lupus erythematosus: a case report. Clin Rheumatol (2008) 0.79
Skin autofluorescence relates to soluble receptor for advanced glycation end-products and albuminuria in diabetes mellitus. J Diabetes Res (2013) 0.79
Comparison of three methods for determination of glucose. Prague Med Rep (2010) 0.79